Sanofi Ventures

Company

Related News

Gene Therapies for Inherited Eye Diseases Advance to Clinical Trials

Mar 06, 2026

Two gene therapies for inherited eye diseases have progressed to clinical trials, with the FDA clearing Sanaregen's SVT-001 for Familial Drusen and SpliceBio treating its first patient in a Stargardt disease trial in Oxford.

Korsana Biosciences Emerges With $175M to Develop Next-Generation Alzheimer's Therapy

Feb 19, 2026

Korsana Biosciences launched from stealth with $175 million in funding to advance KRSA-028, a monoclonal antibody targeting amyloid beta plaques in Alzheimer's disease using a blood-brain barrier shuttle technology.